Grow Therapy
PrivateLast Round
Series D
Mar 3, 2026
Est. Valuation
$3B
Total Funding Raised
$329.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Grow Therapy operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series D round in March 2026.
Grow Therapy is a mental health care company that provides a technology-enabled platform to connect patients with in-network therapists and psychiatrists while supporting independent providers with practice management tools.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement, Vertical SaaS
Business Model
B2B2C
Customer Profile
Marketplace Commission, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grow Therapy Comparables
Compare Grow Therapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Headway | 95% | |
| SonderMind | 86% | |
| Rula | 85% |
For institutional investors. Book with your work email.
Grow Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 3, 2026 | ||||
| Series C | Apr 8, 2024 | ||||
| Series B | Sep 29, 2022 | ||||
| Series A | Sep 23, 2021 | ||||
| Seed | Oct 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Grow Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Able Partners | Seed |
| Plus Capital | Series C |
| TCV | Series C, Series B |
| Gaingels | Seed |
| British Columbia Investment Management Corporation | Series D |
| TCV | Series A, Series C, Series D, Series B |
| Sequoia Capital | Series D, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Partnered with Amazon to offer mental health services to employees.
- Apr 18, 2026
Served hundreds of thousands of clients since February 2021.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- increases_headcount_byNov 4, 2026
Grow Therapy plans to add 123 full-time jobs in New York as it expands its operations, including a larger office and $9.9 million in research and development investment.
- increases_headcount_byNov 4, 2026
On Nov 4th '26, Grow Therapy commits to creating 309 new full-time jobs and retaining 94 positions in New York as part of its expansion, including a new office and $40.9 million in operations investment since November 2025.
- expands_offices_inNov 4, 2026
Grow Therapy expands its New York City presence with a more than 78,000-square-foot Lower East Side office, creating 123 jobs and investing $24.9 million in the project on Nov 4th '26.
- acquiresSep 16, 2026
Grow Therapy acquires Tenor Therapy, Inc., an AI scribe company, just before its $150 million Series D in Q1 '26.
- is_developingAug 20, 2026
Grow Therapy develops Compass Parenting with clinical psychologist Dr. Jacinta Jimenez as a framework for raising children in a complex, technology-centered world and introduces it in New York on Aug 20th '26.
For institutional investors. Book with your work email.
Grow Therapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Grow Therapy's valuation, stock price, and market status.
Is Grow Therapy a public or private company?
Grow Therapy is a private company.
What is the current stock price of Grow Therapy?
Grow Therapy is a private company, so its shares have no public market price. Caplight tracks Grow Therapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Grow Therapy worth (valuation)?
Grow Therapy's valuation is estimated at $3.0B based on funding round data.
Can I buy Grow Therapy stock?
Grow Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Grow Therapy's last funding round?
Grow Therapy's most recent funding round was Series D on March 3, 2026.
Who are the main investors in Grow Therapy?
Key investors in Grow Therapy include TCV, TCV, Sequoia Capital, Goldman Sachs Growth Equity, Goldman Sachs Alternatives.
Will Grow Therapy IPO soon?
No public IPO plans have been announced for Grow Therapy.
How can I track Grow Therapy secondary market activity?
Caplight tracks bids, offers, and trades in Grow Therapy's shares on secondary markets.